Eli Lilly's Obesity Drug Success Spurs Japanese Biotech's Anti-Muscle-Wasting Combo Therapy

benzinga.com/news/health-care/25/06/45834370/eli-lillys-obesity-drug-success-spurs-japanese-biotechs-anti-muscle-wasting-combo-therapy

Chugai Pharmaceutical Co. Ltd. (OTC:CHGCY) believes its anti-muscle-wasting drug could be used alongside Eli Lilly And Co.’s (NYSE:LLY) oral obesity pill, orforglipron.
Roche Holdings AG (OTC:RHHBY) is a major shareholder of Chugai, a Japanese pharmaceutical company. The company’s…

This story appeared on benzinga.com, 2025-06-09 12:11:54.
The Entire Business World on a Single Page. Free to Use →